Recombinant hepatitis B vaccine and the risk of multiple sclerosis: a prospective study

Neurology. 2005 Apr 12;64(7):1317; author reply 1318. doi: 10.1212/wnl.64.7.1317-a.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bias
  • Case-Control Studies
  • Causality
  • Data Interpretation, Statistical
  • Databases, Factual / standards
  • Hepatitis B Antibodies / immunology
  • Hepatitis B Vaccines / adverse effects*
  • Hepatitis B Vaccines / immunology
  • Hepatitis B virus / immunology
  • Humans
  • Immunocompromised Host / drug effects
  • Immunocompromised Host / immunology
  • Multiple Sclerosis / chemically induced*
  • Multiple Sclerosis / immunology
  • Multiple Sclerosis / physiopathology
  • Prospective Studies
  • Recombinant Proteins / adverse effects*
  • Recombinant Proteins / immunology
  • Reproducibility of Results
  • Retrospective Studies
  • United Kingdom

Substances

  • Hepatitis B Antibodies
  • Hepatitis B Vaccines
  • Recombinant Proteins